中文
Company News
- Protheragen-ING Announces Supply of Anti-Tumor APIs, Hypoglycemic APIs, and APIs for Parki... 3/24/2025
- Protheragen-ING Unveils Its Popular Active Pharmaceutical Ingredients 3/21/2025
- Protheragen-ING Offers a Full Range of Nonsteroidal Anti-inflammatory APIs 2/21/2025
- Protheragen-ING’s AI-Synthesizer Helps to Streamline the Synthesis of Small Molecule Drugs 2/14/2025
- Protheragen-ING Provides Comprehensive Microneedle Technology Solutions to Achieve Enhance... 1/21/2025
- Protheragen-ING Releases Hundreds of APIs: Anti-Tumor APIs, Hypoglycemic APIs, Antipsychot... 12/26/2024
- Protheragen-ING Lab Launches Comprehensive Pharmaceutical Safety Evaluation Services 12/20/2024
- Protheragen-ING AI-Pharma’s AI-Powered Drug Discovery and Design Platform—A Paradigm Shift... 11/22/2024
- Protheragen-ING Announces Lyophilized Flash-release Formulations Development Capabilities 11/15/2024
- Protheragen-ING Joins the DCAT Association 5/29/2024
- Protheragen-ING Announces Participation in the 2024 CPHI North America Conference 5/15/2024
- Protheragen-ING Lab, a Trustworthy GLP Service Provider, Unveils Its Cutting-Edge Medical ... 4/29/2024
- Protheragen-ING Announces Supply of Varieties of Veterinary Products for Medical Studies 4/25/2024